Immuno-oncology collaboration to develop innovative new type of cancer drug 18 Apr 2023 Scientists at The Institute of Cancer Research, London, are teaming up with small molecule neoantigen immuno-oncology company NeoPhore to develop new potential cancer drugs. Find out more Show/Hide
Study opens route to overcoming drug resistance in stomach cancer 23 Oct 2022 Scientists have shown how stomach cancers can dodge the effects of a promising new experimental treatment – raising the possibility of outsmarting cancer by predicting drug resistance in advance. Find out more Show/Hide
Triple negative breast cancer’s reliance on sperm and egg production proteins may offer new treatment pathways 12 Oct 2022 Scientists have discovered the key role of a series of proteins in the survival of some triple negative breast cancers. Find out more Show/Hide
AACR 2022: Team of scientists and clinicians wins global award for transforming breast cancer treatment 04 Apr 2022
ESMO Virtual Plenary 2022: Major trial shows targeted drug improves survival in early-stage breast cancer with inherited BRCA1 or BRCA2 mutation 16 Mar 2022
ASCO 2021: Trial shows benefits of targeted drug against early-stage breast cancer with inherited BRCA mutation 03 Jun 2021